Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Why Health Canada’s Recent Announcement Could Be Bad News for Canopy Growth (TSX:WEED)

Published 2019-05-17, 10:16 a/m
Updated 2019-05-17, 10:36 a/m
Why Health Canada’s Recent Announcement Could Be Bad News for Canopy Growth (TSX:WEED)

We could be seeing a lot more competition in the cannabis industry very soon.

Health Canada recently announced that it would be making it easier for companies to obtain cannabis licenses. Previously, applicants didn’t have to have their sites ready to go before submitting their applications, which has created a lot of back-and-forth that wasn’t necessary that the government felt resulted in a lot of inefficiencies and bottlenecks along the way.

With a supply shortage of cannabis in Canada, there’s definitely an incentive to expedite the process. By requiring applicants to have a site already built and in compliance with regulations right at the start, it will help streamline the process and ensure that time isn’t being wasted on applicants that still have a long ways to go.

More competition could be bad news for industry leaders While a company like Canopy Growth Corp (TSX:WEED)(NYSE:CGC) might be enjoying its place atop the industry today, more competition will make it more difficult for the company to keeps its advantage and strong market share. With advertising in the industry being limited, there’s not much of an advantage Canopy Growth can have over its rivals, especially in Ontario, where restrictions around store ownership mean it will have limited say in the retail side of things.

And with an increase in competition, that will help drive down prices and give consumers more options to choose from. Both of those consequences will have a negative impact on Canopy Growth’s financials, which aren’t all that strong to begin with. While some of the more promising competitors have been acquired by Canopy Growth and other big cannabis companies, further acquisitions will require cash being spent or a company having to issue new shares, resulting in dilution for existing shareholders.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Industry leaders don’t want to see too much competition, as it will result in more effort being needed to win market share by driving costs and prices down as much as possible. Although Canopy Growth has managed to turn a profit in two of its past five quarters, operationally it has been nowhere near break even as it has been other income that has been able to land the company into the black.

Bottom line For consumers, the news from Health Canada is a big win. By getting more growers and producers out there, it’ll help the industry meet demand and hopefully keep more customers from having to go to the black market. However, with the possibility for even more fragmentation in an industry that already has lot of small companies vying for market share, it’s going to make it more difficult for a single company to dominate the market.

The key will lie in acquisitions, and that’s where having a strong balance sheet and lots of cash on hand is going to be paramount to staying near the top of the industry. For Canopy Growth, that could be a problem, especially with the company focusing on the U.S. market lately.

Fool contributor David Jagielski has no position in any of the stocks mentioned.

The Motley Fool’s purpose is to help the world invest, better. Click here now for your free subscription to Take Stock, The Motley Fool Canada’s free investing newsletter. Packed with stock ideas and investing advice, it is essential reading for anyone looking to build and grow their wealth in the years ahead. Motley Fool Canada 2019

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

This Article Was First Published on The Motley Fool

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.